三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
总体人群PFS曲线(IRC评估)
总体人群PFS曲线(IRC评估)
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:254KB
图片尺寸:1113*843
同报告图片
/
4
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
所属报告:
中国生物制药-港股公司研究报告-Pharma转型成效显著自主创新与开放合作并重前行-250208(42页).pdf
打包全文图表
相关数据
ZG005治疗宫颈癌患者的无进展生存期(IRC评估)
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
收藏
行业数据
2026-06-26
原图定位
查看详情
依沃西为全球首个在三期临床中头对头击败K药的新药,PFS强阳性(HR=0.51)
收藏
行业数据
2026-03-31
原图定位
查看详情
HARMONi-6试验主要终点:依沃西+化疗较对照臂PFS提升4.2个月(HR=0.60)
收藏
行业数据
2026-03-31
原图定位
查看详情
CARTITUDE-4 TME: Patients With Shorter PFS (≤18M) and Patients With More pLOT had a More Suppressive TME
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
收藏
行业数据
2026-03-11
原图定位
查看详情
CARTITUDE-4: PFS and OS in Patients With Standard-Risk Cytogenetics (As-Treated)
fCDnu4TliKsgfCAzMOS4quaciOaXoOi/m+WxleeUn+WtmOeOh++8iFBGUywgJe+8iSB8IDMw5Liq5pyI5oC755Sf5a2Y546H77yIT1MsICXvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCBDQVJUSVRVREUgLSA0IOagh+WHhumjjumZqSB8IDgwLjUgfCA4Ny4zIHwKfCBDQVJUSVRVREUgLSA0IOagh+WHhumjjumZqSArIGdhaW4vYW1wKDFxKSB8IDcxLjcgfCA4Ni4xIHwKCui1hOaWmeadpea6kO+8mlBBUlRJVFVERSAtIDQg56CU56m277yI5qCH5YeG6aOO6Zmp57uG6IOe6YGX5Lyg5a2m5oKj6ICFIEFzIC0gVHJlYXRlZCDliIbmnpDvvInmlbDmja4=
收藏
行业数据
2026-03-11
原图定位
查看详情
Figure 3: PFS (A) and OS (B)
fCDmjIfmoIcgICAgICAgfCAzNuS4quaciOeOhyB8IDk1JSDnva7kv6HljLrpl7QgfAp8LS0tLS0tLS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS18CnwgUEZTICAgICAgICB8IDkzLjglICAgIHwgNjMuMuKAkzk5LjEgICAgfAp8IE9TICAgICAgICAgfCA5My44JSAgICB8IDYzLjLigJM5OS4xICAgIHwKCui1hOaWmeadpea6kO+8muWbvueJh+S4reKAnFJlc3VsdHPigJ3mnb/lnZflj4pGaWd1cmUgM++8iFBGUyAoQSkg5ZKMIE9TIChCKe+8ieWGheWuueOAgg==
收藏
行业数据
2026-03-11
原图定位
查看详情
T-DXd对HER2-lowBC的全人群PFS
fCDpobnnm64gICAgICAgICAgICAgICAgfCBULURYZCAgICAgICB8IFRQQyAgICAgICAgIHwKfC0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS18Cnwg5Lit5L2N5peg6L+b5bGV55Sf5a2Y5pyfKG1vKSB8IDkuOSAgICAgICAgIHwgNS4xICAgICAgICAgfAp8IOmjjumZqeavlChIYXphcmQgUmF0aW8pIHwgMC41MCAgICAgICAgfCAtICAgICAgICAgICB8CnwgOTUl572u5L+h5Yy66Ze0KDk1JSBDSSkgIHwgMC40MCAtIDAuNjMgfCAtICAgICAgICAgICB8CnwgUOWAvCAgICAgICAgICAgICAgICAgfCA8IDAuMDAwMSAgICB8IC0gICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muesrOS4gOS4ieWFse+8jEFTQ08gMjAyMu+8jOeIseW7uuivgeWIuOeglOeptuaJgA==
收藏
行业数据
2025-11-24
原图定位
查看详情
Ivonescimab国内临床,PFS显著优于K药
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
收藏
行业数据
2025-10-24
原图定位
查看详情
izabren展现EGFRmNSCLC二线治疗历史最长PFS(单位:月)
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
收藏
行业数据
2025-09-16
原图定位
查看详情
Vepdegestrantvs氟维司群在HR+/HER2-BC(全人群)的PFS数据
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
收藏
行业数据
2025-08-08
原图定位
查看详情
R/RCLL最新PFS数据支持BGB-16673开展与匹妥布替尼的头对头试验
fCDpobnnm64gfCBCR0ItMTY2NzMgfCDljLnlronluIPmm7/lsLwgfAp8LS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tLXwKfCBuICAgIHwgNjYgICAgICAgfCAxMTkgICAgICB8Cnwg5Lit5L2NUEZTLCDmnIggKDk1JSBDSSkgfCAyMi44ICgxNS42KSB8IDE0LjAgKDExLjItMTYuNikgfAp8IOS4reS9jemaj+iuv+aXtumXtCwg5pyIIHwgMTUuNiAgICAgIHwgMTkuNCAgICAgIHw=
收藏
行业数据
2025-08-07
原图定位
查看详情
CELESTIAL-301临床:全球唯一旨在证明相比目前固定疗程标准疗法具有PFS
fCDliIblsYLlm6DntKAgfCBB57uEIHwgQue7hCB8CnwtLS0tLS0tLS0tLXwtLS0tLXwtLS0tLXwKfCDlubTpvoQoPDY15bKB5a+55q+U4omlNjXlsoEpIHwgICAgIHwgICAgIHwKfCBJR0hWKOeqgeWPmOWvueavlOacqueqgeWPmCkgfCAgICAgfCAgICAgfAp8IOaYr+WQpuS8tOaciTE3cOe8uuWksS9UUDUz56qB5Y+YIHwgICAgIHwgICAgIHwKCui1hOaWmeadpea6kO+8muWFrOWPuOa8lOekuuadkOaWme+8jOWbvemHkeivgeWIuOeglOeptuaJgA==
收藏
行业数据
2025-08-07
原图定位
查看详情
无明确驱动基因NSCLC(无论PD-L1表达状态),依沃西PFS数据佳,SSGJ-707的ORR及安全性佳
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
收藏
行业数据
2025-07-17
原图定位
查看详情
Tarlatamab在PFS及癌症相关呼吸/咳嗽获益
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
收藏
行业数据
2025-07-15
原图定位
查看详情
戈利昔替尼与西达本胺的PFS曲线对比
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
收藏
行业数据
2025-06-23
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
安全性方面表现良好:依奉阿克和克唑替尼≥3级治疗相关不良事件(TRAE)发生率为51.9% vs 40.6%,因 TRAE 导致的停药率分别为 4.6%和 3.0%,依奉阿克组因 TRAE 用药暂停、终止治疗或死亡的发生率较低。且依奉阿克组大多为 1-2 级 AEs,最常见的 TRAEs 包括腹泻、呕吐、ALT 升高、恶心和 AST 升高等,血液相关毒性较低。
行业数据
原图定位
当前图表所属:
中国生物制药-港股公司研究报告-Pharma转型成效显著自主创新与开放合作并重前行-250208(42页).pdf
中国生物制药的生物类似物管线进展
中国生物制药MASH领域布局
天晴甘美上市以来销售额/百万美元,截止至2019年
全球PDE3/4抑制剂研发进展
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》